BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home » Authors » Larry Haimovitch

Larry Haimovitch

Articles

ARTICLES

When a deal value deferred by milestones is still a good deal

March 7, 2011
By Larry Haimovitch

CAE vs. CAS heatedly debated by numerous surgeons at ISC meeting

March 1, 2011
By Larry Haimovitch

ISC spotlight is focused on acute ischemic stroke

Feb. 17, 2011
By Larry Haimovitch
LOS ANGELES — The annual International Stroke Conference, (ISC) sponsored by the American Heart Association (AHA; Dallas) was held here last week. One of the key topics was the treatment of an acute ischemic stroke (AIS). (Medical Device Daily)
Read More

CAE vs. CAS heatedly debated at ISC session

Feb. 14, 2011
By Larry Haimovitch
LOS ANGELES — The purpose of a clinical trial, particularly a huge, multi-center, prospective and randomized one, is to provide sufficient data to guide physicians to deliver the best care for their patients. The vast majority of trials, whether device or drug-based, generally achieve this goal. (Medical Device Daily)
Read More

Cardiothoracic surgeons learn of latest surgical innovations

Feb. 1, 2011
By Larry Haimovitch
SAN DIEGO — The 47th annual meeting of the Society of Thoracic Surgeons (STS; Chicago) which is taking place here, was well-attended as cardiothoracic (CT) surgeons gathered to meet and gain up-to-date information on their subspecialty. (Medical Device Daily)
Read More

Private companies whet the appetites of attendees

Jan. 17, 2011
By Larry Haimovitch
SAN FRANCISCO – This annual conference, which in recent years has become the "must go-to" healthcare meeting, offers something for just about everyone's appetite. And, for those of us who are interested in earlier stage, private companies there was a rich menu to choose from.(Medical Device Daily)
Read More

Word on the Street: Despite difficulties, med-tech industry still having success

Jan. 4, 2011
By Larry Haimovitch

Investors' hearts racing at cardio company presentations

Dec. 13, 2010
By Larry Haimovitch

Private med-tech firms see rosy futures in varied spaces

Dec. 7, 2010
By Larry Haimovitch
NEW YORK — The 22nd annual Piper Jaffray (Minneapolis) Health Care Conference took place here last week. As usual, the conference was very well-attended by a wide variety of constituents from the financial community and, as always, featured an exciting roster of both public and private med-tech companies. (Medical Device Daily)
Read More

Recent deals offer hope for beleaguered VC model

Nov. 29, 2010
By Larry Haimovitch
View All Articles by Larry Haimovitch

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing